explore -WSS

explore

author：knowledge 2025-09-28 08:53:39 - browse：46823

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Black vets could get higher VA benefits if race not used in lung test

WSS

RaDonda Vaught links Vanderbilt hospital issues to patient death

Has Bernie Sanders reached the limit of his pharma bullying effort?

Steward Health Care Massachusetts hospitals face fiscal disaster

HHS secretary Becerra pressed on Change HealthCare cyberattack

Class action alleges UnitedHealth concealed DOJ probe

WuXi out of biotech trade group, U.S. and China relations to blame

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Medicare details structure of new drug price negotiation program

Black vets could get higher VA benefits if race not used in lung test

Trump demands the U.S. pay no more for drugs than other countries … again

PBM executives asked to testify by House panel

Medicare proposal to cover medical devices draws a mixed reaction

PBM executives asked to testify by House panel

In Memoriam: Notable people who died in 2023

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Brain MRIs reveal impact of 'toxic stress' on Black children

knowledge

Deliver public health messages at the right time

HHS's proposed rule does nothing to address the climate crisis

Most antidepressants don't work on kids, teens, study finds

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Chemotherapy before breast cancer surgery might fuel metastasis

How to save health care price transparency rules

hotspot

Wikipedia

focus

hotspot